NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Thibaud Valentin
Institut Claudius Regaud - Toulouse / France
Others
AD Scientific Index ID: 4608732
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Thibaud Valentin's MOST POPULAR ARTICLES
1-)
Management and prognosis of malignant peripheral nerve sheath tumors: the experience of the French Sarcoma Group (GSF-GETO)T Valentin, A Le Cesne, I Ray-Coquard, A Italiano, G Decanter, E Bompas, ...European journal of cancer 56, 77-84, 20161202016
2-)
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trialA Le Cesne, JY Blay, J Domont, E Tresch-Bruneel, C Chevreau, ...The Lancet Oncology 16 (3), 312-319, 20151002015
3-)
Sorafenib in patients with progressive malignant solitary fibrous tumors: a subgroup analysis from a phase II study of the French Sarcoma Group (GSF/GETO)T Valentin, C Fournier, N Penel, E Bompas, L Chaigneau, N Isambert, ...Investigational new drugs 31 (6), 1626-1627, 2013602013
4-)
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trialJY Blay, S Chevret, A Le Cesne, M Brahmi, N Penel, S Cousin, F Bertucci, ...The Lancet Oncology 24 (8), 892-902, 2023
5-)
Surgical margins and adjuvant therapies in malignant phyllodes tumors of the breast: a multicenter retrospective studyM Neron, C Sajous, S Thezenas, S Piperno-Neumann, F Reyal, M Laé, ...Annals of surgical oncology 27, 1818-1827, 2020
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept